Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on August 3, 2006

Stroke. 2006
Published online before print August 3, 2006, doi: 10.1161/01.STR.0000236638.75591.61
A more recent version of this article appeared on September 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/9/2283    most recent
01.STR.0000236638.75591.61v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Htun, P.
Right arrow Articles by Gawaz, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Htun, P.
Right arrow Articles by Gawaz, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Stroke
*Transient Ischemic Attack
Related Collections
Right arrow Pathophysiology
Right arrow Aggregation
Right arrow Acute Cerebral Infarction
Right arrow Acute Stroke Syndromes
Right arrow Antiplatelets
Right arrow Transient Ischemic Attacks
Right arrow Platelets

Submitted on January 13, 2006
Revised on May 3, 2006
Accepted on May 30, 2006

Course of Platelet Activation and Platelet-Leukocyte Interaction in Cerebrovascular Ischemia

Patrik Htun MD; Suzanne Fateh-Moghadam MD; Bernd Tomandl MD; René Handschu MD; Kathrin Klinger MD; Konstantinos Stellos MD; Christoph Garlichs MD; Werner Daniel MD; and Meinrad Gawaz MD*

From the Medizinische Klinik mit Schwerpunkt Nephrologie und Intensivmedizin (P.H.), Medizinische Klinik mit Schwerpunkt Kardiologie (S.F.-M), Charité-Campus Virchow-Klinikum, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin und Freie Universität Berlin, Berlin; Klinik für Neuroradiologie (B.T.), Klinikum Bremen Mitte, Bremen; Neurologische Klinik (R.H.), Friedrich Alexander Universität, Erlangen-Nürnberg; Medizinische Klinik mit Schwerpunkt Nephrologie IV (K.K.), Friedrich Alexander Universität, Erlangen Nürnberg; Medizinische Klinik III (K.S., M.G.), Universitätsklinikum, Tübingen; and Medizinische Klinik mit Schwerpunkt Kardiologie (C.G., W.D.), Friedrich Alexander Universität, Erlangen-Nürnberg, Germany.

* To whom correspondence should be addressed. E-mail: meinrad.gawaz{at}med.uni-tuebingen.de.

Background and Purpose--Platelet activation plays a crucial role in the pathophysiology of cerebral ischemia. The aim of this study was to investigate the contribution of platelet activation and leukocyte-platelet interactions to the disease.

Methods--One hundred thirty-five patients with transient ischemic attack (TIA) or stroke were enrolled in this single-center study. They underwent cranial computer tomography within 24 hours of clinical onset and after 3 months, and systemic venous blood samples were drawn. Platelet activation (CD62P expression), leukocyte activation (L-selectin expression), and the appearance of platelet-specific antigens on leukocytes as an index of platelet-leukocyte aggregation were measured by flow cytometric techniques in the acute state and at 3-month follow-up.

Results--Patients with a completed stroke or TIA had significantly increased circulating platelet-leukocyte aggregates, increased P-selectin expression on platelets, and decreased L-selectin expression in the acute state compared with the control group (healthy volunteers). No differences in regard to the tested activation markers could be detected between patients with stroke or TIA in the acute phase of the disease. However, platelet and leukocyte activations were normalized after 3 months in patients with TIA, whereas leukocyte activation (reduced L-selectin expression) remained in stroke patients.

Conclusions--In patients with TIA and completed stroke, platelet and leukocyte activation is substantially enhanced in the acute phase of the disease. The sustained leukocyte activation observed in stroke but not in TIA patients at 3-month follow up might play a pathophysiological role in the course of the disease.


Key words: cerebral ischemia, transient • leukocytes • platelet activation • platelets • stroke




This article has been cited by other articles:


Home page
StrokeHome page
H.-K. Yip, L.-T. Chang, W.-N. Chang, C.-H. Lu, C.-W. Liou, M.-Y. Lan, J. S. Liu, A. A. Youssef, and H.-W. Chang
Level and Value of Circulating Endothelial Progenitor Cells in Patients After Acute Ischemic Stroke
Stroke, January 1, 2008; 39(1): 69 - 74.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Villagra, S. Shiva, L. A. Hunter, R. F. Machado, M. T. Gladwin, and G. J. Kato
Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin
Blood, September 15, 2007; 110(6): 2166 - 2172.
[Abstract] [Full Text] [PDF]